
An investor, who purchased shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA), filed a lawsuit against Centessa Pharmaceuticals plc over alleged Federal Securities Laws violations in connection with the Company's initial public offering conducted on or about May 28, 2021 (the "IPO" or "Offering") and between May 28, 2021 and June 1, 2022.